Aligos appoints Heather Preston and Margarita Chavez to Board

Aligos Therapeutics, Inc.

Board expanded to seven directors; Preston and Chavez appointed as Class II directors through 2025 annual meeting.
Dr. Preston will chair the Nominating Committee; Ms. Chavez joins the Audit Committee.
Each receives $40k annual retainer (prorated) and an initial option for 120,000 shares.
Chavez gets additional $7,500/yr for Audit; Preston gets $8,000/yr for Nominating chair (both prorated).
Both entered standard indemnification agreements; no material relationships requiring disclosure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Heather Preston

Director

ALGS · Aligos Therapeutics, Inc.

Effective: 2024-08-07
Filed: August 8, 2024, 7:59 PM ET

appointed Heather Preston, M.D. and Margarita Chavez, J.D., to the Board to fill the newly created directorships

Appointed

Margarita Chavez

Director

ALGS · Aligos Therapeutics, Inc.

Effective: 2024-08-07
Filed: August 8, 2024, 7:59 PM ET

appointed Heather Preston, M.D. and Margarita Chavez, J.D., to the Board to fill the newly created directorships

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Heather Preston was appointed as Director at Aligos Therapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Heather Preston, M.D. and Margarita Chavez, J.D., to the Board to fill the newly created directorships

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Margarita Chavez was appointed as Director at Aligos Therapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Heather Preston, M.D. and Margarita Chavez, J.D., to the Board to fill the newly created directorships

View on SEC.gov

Aligos Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-196966

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.